Special Episode from the 55th Annual ASAM Conference: Dr. Kelly Ramsey

For this special episode recorded live at ASAM’s Annual Conference, Kelly Ramsey, MD, MPH, MA, FACP, DFASAM, talks about her journey into the field of addiction medicine and how her early experience dispelled myths she previously heard about people who use drugs. She addresses stigma related to addiction, the prevalence of xylazine in the illicit drug supply*, and the need to recognize and treat appropriately polysubstance drug use and overdoses. Dr. Ramsey also discusses her thoughts about the future of addiction medicine and the importance of harm reduction and meeting patients where they are. She shares what she finds enjoyable about attending ASAM’s conference and offers words of wisdom to the new generation of addiction medicine providers. Dr. Ramsey is a board-certified internal medicine and addiction medicine physician who has treated substance use disorder since 2004. She worked as medical director of an academic center-based opioid treatment program (OTP) in the South Bronx before working for nearly a decade for a large FQHC in the Hudson Valley where she created and grew a medication for addiction treatment (MAT) program for opioid use disorder (OUD) and alcohol use disorder (AUD) to 10 sites and 1500 patients. More recently, Dr. Ramsey worked as the chief of medical services at the NYS Office of Addiction Services and Supports (OASAS), in a policy, regulatory, and clinical role. Dr. Ramsey currently works as an addiction medicine and harm reduction consultant as well as providing low threshold clinical care and clinical supervision in addiction medicine in three drug user health hubs in New York. She has provided expert advice to the New York State Department of Health (NYSDOH) AIDS Institute and their Office of Drug User Health (ODUH), serving on numerous committees for about 15 years, providing expertise in addiction medicine, harm reduction, HIV care, and HCV care. Dr. Ramsey was the recipient of the New York State Commissioner’s Special Recognition Award for contributions to drug user health in NYS in December 2018. She was the Distinguished Contributions to Behavioral Medicine Award Recipient, awarded by the American College of Physicians (ACP) in April 2023. Dr. Ramsey was awarded the Case Western Reserve University School of Medicine Special Medical Alumni Board Award in October 2023. Dr. Ramsey is the immediate past president of the New York Chapter of the American Society of Addiction Medicine (NYSAM) Board of Directors. In addition, she currently serves as Region I Director, representing NYS, on the national American Society of Addiction Medicine (ASAM) Board of Directors. Links: ASAM’s Annual Conference information Finding Lifesaving Solutions to a Dangerous Trend American Society of Addiction Medicine   If you or someone you know is struggling with addiction, you are not alone. Treatment is available and recovery is possible. Visit ASAM’s Patient Resources page for more information. The information shared in this podcast episode is for educational purposes only and should not be taken as medical advice. The views expressed in this podcast may not be those of the host or the management.   *The comments in the discussion alluding to 90% of syringes containing xylazine refer to the findings of the following study: The Emerging of Xylazine as a New Drug of Abuse and its Health Consequences among Drug Users in Puerto Rico - PMC (nih.gov).